WO2004072255A3 - Methods of treating disease - Google Patents

Methods of treating disease Download PDF

Info

Publication number
WO2004072255A3
WO2004072255A3 PCT/US2004/003779 US2004003779W WO2004072255A3 WO 2004072255 A3 WO2004072255 A3 WO 2004072255A3 US 2004003779 W US2004003779 W US 2004003779W WO 2004072255 A3 WO2004072255 A3 WO 2004072255A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
methods
compositions
treating disease
disease
Prior art date
Application number
PCT/US2004/003779
Other languages
French (fr)
Other versions
WO2004072255A2 (en
Inventor
Robert Zelle
Original Assignee
Scion Pharmaceuticals Inc
Robert Zelle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scion Pharmaceuticals Inc, Robert Zelle filed Critical Scion Pharmaceuticals Inc
Publication of WO2004072255A2 publication Critical patent/WO2004072255A2/en
Publication of WO2004072255A3 publication Critical patent/WO2004072255A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to substituted-guanidinyl compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.
PCT/US2004/003779 2003-02-11 2004-02-09 Methods of treating disease WO2004072255A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44648603P 2003-02-11 2003-02-11
US60/446,486 2003-02-11

Publications (2)

Publication Number Publication Date
WO2004072255A2 WO2004072255A2 (en) 2004-08-26
WO2004072255A3 true WO2004072255A3 (en) 2004-11-25

Family

ID=32869518

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/003779 WO2004072255A2 (en) 2003-02-11 2004-02-09 Methods of treating disease

Country Status (1)

Country Link
WO (1) WO2004072255A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines

Also Published As

Publication number Publication date
WO2004072255A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
WO2005086836A3 (en) Ion channel modulators
WO2005086895A3 (en) Ion channel modulators
WO2005086902A3 (en) Ion channel modulators
WO2005097112A3 (en) Ion channel modulators
WO2008033562A3 (en) Kinase inhibitor compounds
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2006086562A3 (en) Phenylazetidinone derivatives
EA200700225A1 (en) TETRAPTIDE ANALOGUES
WO2006102504A3 (en) Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors
WO2006042249A3 (en) Methods and compositions for treating migraine pain
WO2006044775A3 (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
WO2007016538A3 (en) Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2004100881A3 (en) Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
MX2007005590A (en) Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof.
BRPI0508537A (en) Ion channel modulators
EA200600078A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES
WO2006009975A3 (en) Histamine to treat disorders affecting muscle function
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
BRPI0508550A (en) ion channel modulators
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
WO2006113718A3 (en) Compositions for the treatment of neoplasms
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
HK1102626A1 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
WO2006091544A3 (en) Methods and compositions for modulating calcium channels

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase